Benefit of tegafur-uracil and leucovorin in chemoradiotherapy for rectal cancer.

@article{Ishihara2011BenefitOT,
  title={Benefit of tegafur-uracil and leucovorin in chemoradiotherapy for rectal cancer.},
  author={Soichiro Ishihara and Tamuro Hayama and Hideki Yamada and Keijiro Nozawa and Keiji Matsuda and Toshiaki Watanabe},
  journal={Hepato-gastroenterology},
  year={2011},
  volume={58 107-108},
  pages={756-62}
}
BACKGROUND/AIMS Concomitant chemotherapy increases the therapeutic effect of preoperative radiotherapy for rectal cancer. The aim was to investigate the clinical benefit of tegafur-uracil (UFT) and leucovorin (LV) in preoperative chemoradiotherapy for rectal cancer. METHODOLOGY Patients who had undergone curative resections of rectal cancers following preoperative radiotherapy (50-50.4Gy) with UFT and LV (CRT group: n=30) or radiotherapy without chemotherapy (RT group: n=33) were studied… CONTINUE READING
6 Citations
0 References
Similar Papers

Similar Papers

Loading similar papers…